Assura, a UK primary care property investor and developer, has unveiled £105 mln (€126 mln) of recent acquisitions.
According to the Warrington-headquartered REIT, the firm completed nine deals in the fourth quarter of 2021, bringing its total portfolio to 634 properties.
Said Jonathan Murphy, Assura CEO: 'It has been another strong quarter of progress as we have swiftly deployed the proceeds of our successful November equity placing.
'Our experienced internal investment and development teams have ensured activity continues apace. In the last quarter we completed £105 mln of acquisitions. We have also moved on site with two new development schemes and are currently on site with 14 schemes at a total
cost of £97 mln.'
Assura works with GPs, health professionals and the NHS to create spaces for health services across the UK. As of 30 September 2021, Assura's property portfolio was valued at £2.6 bn.
The company said it had an immediate development pipeline of 22 schemes, where it expects to be onsite within 12 months, totalling a further £166 mln.
It also has an immediate acquisitions pipeline of £71 mln in legal hands, which it hopes to complete in 3-6 months. Assura is planning for 62 lease re-gears covering £7.7 mln of existing rent in the current pipeline, and a pipeline of 16 capital asset enhancement projects over the next two years.
Concluded Murphy: 'As the booster and vaccination programmes continue - with some of our buildings acting as major hubs - the urgent need for high-quality primary care capacity to support the significant effort required to address the backlog from the pandemic will be in even sharper focus in the coming months.
'Assura continues to be a partner of choice to the NHS in helping to deliver this critical capacity.'
